News: St. Jude Medical Inc (STJ)
9 Dec 2013
Wed, Oct 16 2013
* Gained share in U.S. for implantable cardioverter defibrillators - CEO
Oct 16 - St. Jude Medical posted a 49 percent jump in third-quarter profit as increased sales of devices to treat abnormal heart rhythms offset a decline in sales of pacemakers.
Sept 6 - (The following statement was released by the rating agency)
Aug 20 - Medtronic Inc on Tuesday reported a first-quarter profit in line with expectations on solid growth in emerging markets, but soft U.S. demand for implantable heart defibrillators weighed on its shares, which slumped more than 2 percent.
BRUSSELS, Aug 19 - Gimv: * Belgium's Gimv sells portfolio company Endosense to St Jude Medical
STOCKHOLM - Budget fashion retailer Hennes & Mauritz launched an e-commerce operation in the United States on Thursday, taking on rivals in the world's biggest online market.
- St. Jude Medical Inc on Wednesday posted higher-than-expected quarterly earnings and revenue as sales of devices to treat abnormal heart rhythms improved from earlier this year, sending its shares up 7 percent.
* Company says it has turned the corner on lead wire problems
July 17 - Heart device maker St. Jude Medical Inc on Wednesday posted a lower second-quarter net profit, on costs related to the early retirement of debt.
STOCKHOLM - H&M , the world's second-largest fashion retailer, reported a sharp rise in sales so far in June, with new collections selling well.
- Becton Dickinson Dividend Stock Analysis
- St. Jude Medical's Management Presents at Piper Jaffray Healthcare Conference (Transcript)
- Medtronic's Dividend Worth A Look
- Cyberonics: 7 Different Insiders Have Sold Shares During The Last 30 Days
- Cramer's Lightning Round - The Andersons Must Be Doing Something Right (11/13/13)
- High Expectations Still Hurting Volcano
- St. Jude Medical Board of Directors Authorizes $700 Million Share Repurchase
- St. Jude Medical Announces Fourth Quarter Dividend
- Stock Price Movements, Completed Acquisitions, and New Clinical Studies - Research Report on UnitedHealth Group, Mylan, St. Jude Medical, and Cigna
- St. Jude Medical Begins US Study to Evaluate Combination of Peripheral Nerve Field Stimulation and Spinal Cord Stimulation for Chronic Low Back and Leg Pain
- St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain
- FDA Approvals, Scheduled Presentations, and Stock Price Movements - Research Report on Amgen, St. Jude Medical, Life Technologies, Ligand, and Infinity Pharmaceuticals
- St. Jude Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference
- Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance
- Morning Research: Navidea Biopharma Inc., St. Jude Medical Inc., Hologic Inc., and ResMed Inc.
- Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion